When inflation pressures flare up, like the recent 7.8% jump in the Philippines, investors everywhere are reminded how quickly rising costs can chip away at returns. Australian growth stories where founders and executives hold sizeable stakes can look especially appealing in that context, because leadership is heavily exposed to the same risks and rewards as you. This article unpacks three fast growing, high insider ownership stocks from that universe.
The three stocks highlighted here offer a compelling starting point if you want exposure to fast growing businesses where insiders hold meaningful stakes alongside you. However, if you want the standouts, these 27 high growth high conviction stocks are the most outstanding.
PDI Gold (ASX:PDI)
PDI Gold is a West African gold producer focused on the Kiniéro Gold Mine in Guinea, a growth project that fits the fast growing, high insider ownership theme through ongoing production, expansion plans and management’s optimistic tone on future output and cash generation.
PDI Gold generated about US$156 million of revenue from Kiniéro and US$47 million from Nampala, with Kiniéro the primary economic engine, and the group carries a market value of roughly A$4.5b.
PDI Gold gives you pure exposure to an operating gold complex that already generates refined metal sales, while management and analysts frame Kiniéro as the key lever for future growth that underpins its place in this screener.
"Although Kiniero is ramping strongly with low reported all in sustaining costs and high throughput, the reliance on oxide ore for the next few years means a later shift to harder material could lift unit costs and pressure margins once the current "oxide holiday" ends."
What happens when one less visible cost pressure finally shows up in the numbers could matter more for long term returns than any headline.
When that cost inflection finally bites, the full narrative for PDI Gold shows how PDI Gold’s expansion plans, balance of ore types, and insider alignment could still keep the story accelerating.
Telix Pharmaceuticals (ASX:TLX)
Telix Pharmaceuticals is built around precision radiopharmaceuticals for finding and treating cancer, which fits this screener’s focus on ambitious growth stories backed by confident management. The key question for investors is how far that pipeline and commercial footprint can scale from here.
Telix Pharmaceuticals develops radiopharmaceutical diagnostics and therapies, with about US$705 million from Precision Medicine and US$277 million from Manufacturing Solutions, after adjustments and eliminations, and an A$4.8b market cap.
"Their primary revenue generating imaging agents: 'Illuccix' and 'Gozellix', are utilised in 23+ countries worldwide, including key markets such as the U.S, Europe, China and Japan, with revenue figures of $803.8m (USD) in the 2025 Financial Year (within their already upgraded guidance range) provided for FY25, a cash balance of $141.9m (USD), and the potential growth of Gozellix as its launch into the U.S expands."
What happens if one key assumption about future treatment uptake or pricing shifts will matter a lot for how that promise translates into returns.
That hinge point on future uptake is exactly where the full narrative for Telix Pharmaceuticals shows how Telix Pharmaceuticals could continue to advance, with underappreciated upside and clear pressure points.
Barrenjoey Group (ASX:BJY)
Barrenjoey Group is an Australian investment manager focused on global equities and listed infrastructure strategies, with growth tied closely to its A$205.7 million Investment Management Services arm, alongside Partnerships & Investments of A$40.1 million and a market value near A$2.5b.
Barrenjoey Group gives you exposure to an asset manager where actively managed global equity and listed infrastructure strategies, plus separately managed accounts, aim to grow fee income rather than rely on balance sheet risk.
"The growth of partnership income to A$25.7 million in the first half of FY26, accounting for 31% of operating profit and supported by contributions from Barrenjoey and Vinva, points to a larger role for capital light fee streams that can affect future margins and profit mix."
What happens if one pressure point on those fee streams shifts will matter a lot for how future profitability actually lands.
That pressure point on fee resilience is exactly where the full narrative for Barrenjoey Group shows how Barrenjoey Group’s capital light engine could keep accelerating through different market cycles.
Curious To Explore Stronger Alternatives?
Fresh ideas move first. Once momentum catches, entry points close fast and under the radar stories stop being quiet. Scan what others miss while it still matters, act now.
- Spot cash generative miners before gold momentum really starts flying by scanning the curated 33 elite gold producer stocks that already pass strict balance sheet and quality filters.
- Ride the next wave of AI infrastructure spending by reviewing carefully selected 53 AI infrastructure stocks positioned around data centers, chips, and the plumbing that keeps demand running.
- Target steadier portfolio anchors with a hand picked 5 dividend fortresses list that focuses on resilient payouts and balance sheets built to handle tougher conditions.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com